CRYSTALLINE FORMS OF A 3-[2-METHANESULFONYL-1-(4-TRIFLUOROMETHYL-PHENOXY)ETHYL]PYRROLIDINE COMPOUND

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150141483A1
SERIAL NO

14605187

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides crystalline hydrochloride salts of (S)-3-[(S)-2-methanesulfonyl-1-(4-trifluoromethylphenoxy)ethyl]pyrrolidine. This invention also provides pharmaceutical compositions comprising the crystalline salts, processes and intermediates for preparing the crystalline salts, and methods of using the crystalline salts to treat diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THERAVANCE BIOPHARMA R&D IP LLCSOUTH SAN FRANCISCO CA 94080

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Colson, Pierre-Jean San Francisco, US 42 435
Fass, Timothy San Francisco, US 3 2
Thalladi, Venkat R Foster City, US 52 202

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation